C34.2 is a billable ICD code used to specify a diagnosis of malignant neoplasm of middle lobe, bronchus or lung. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Full Answer
C34. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C34. 2 became effective on October 1, 2021.
C34. 2 - Malignant neoplasm of middle lobe, bronchus or lung. ICD-10-CM.
ICD-10 code: C34. 9 Malignant neoplasm: Bronchus or lung, unspecified.
Secondary malignant neoplasm of unspecified lung The 2022 edition of ICD-10-CM C78. 00 became effective on October 1, 2021.
2022 ICD-10-CM Diagnosis Code C34. 90: Malignant neoplasm of unspecified part of unspecified bronchus or lung.
Associated ICD-10-CM CodesMalignant neoplasm of bronchus and lungC34.90Malignant neoplasm of unspecified part of unspecified bronchus or lungC34.91Malignant neoplasm of unspecified part of right bronchus or lungC34.92Malignant neoplasm of unspecified part of left bronchus or lung18 more rows
The Special Committee on Peacekeeping Operations (C34) was established in 1965 under the General Assembly Fourth Committee in order to review and provide recommendations on United Nations Peacekeeping Operations.
A malignant tumor at the original site of growth. [ from NCI]
A malignant neoplasm of the bronchus and lung, also known as bronchogenic carcinoma or lung cancer, is a malignant cancer that originates in the bronchi, bronchioles, or other parts of the lung. The cancer begins when the cells of the lung begin to mutate.
ICD-10 code C34. 91 for Malignant neoplasm of unspecified part of right bronchus or lung is a medical classification as listed by WHO under the range - Malignant neoplasms .
91 - Malignant neoplasm of unspecified part of right bronchus or lung | ICD-10-CM.
ICD-9 code 162.9 for Malignant neoplasm of bronchus and lung unspecified is a medical classification as listed by WHO under the range -MALIGNANT NEOPLASM OF RESPIRATORY AND INTRATHORACIC ORGANS (160-165).
C34.2 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of middle lobe, bronchus or lung. The code C34.2 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Large cell lung carcinoma with rhabdoid phenotype (LCLC-RP) is a rare histological form of lung cancer, currently classified as a variant of large cell lung carcinoma (LCLC).
The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code C34.2. Click on any term below to browse the neoplasms index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 162.4 was previously used, C34.2 is the appropriate modern ICD10 code.
Malignant neoplasm of unspecified part of bronchus or lung 1 C34.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM C34.9 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C34.9 - other international versions of ICD-10 C34.9 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...